Prognostic significance of bone marrow micrometastases in patients with gastric cancer

Journal of Clinical Oncology

Volumn 14, Issue 6, 1996, Pages 1810-1817

  Jauch, K W ^a   Heiss, M M ^a   Gruetzner, U ^a   Funke, I ^a   Pantel, K ^a   Babic, R ^a   Eissner, H J ^a   Riethmueller, G ^a   Schildberg, F W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

ADULT; AGED; ARTICLE; BONE MARROW CELL; BONE MARROW METASTASIS; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STOMACH CANCER; TREATMENT PLANNING;

EID: 0029977016     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.6.1810     Document Type: Article

References (41)

1. Noguchi Y, Mada T, Matsumoto A, et al: Radical surgery for gastric cancer. Cancer 64:2053-2062, 1989
2. Brisco MJ, Condon J, Hughes E, et al: Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet 343:196-200, 1994
3. Cote RJ, Rosen PP, Hakes TB, et al: Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 12:333-340, 1988
4. Osborne MP, Asina S, Wong GY, et al: Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow sensitivity in a model system. Cancer Res 49:2510-2513, 1989
5. Ellis G, Ferguson M, Yamanaka E, et al: Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients. Cancer 63:2509-2514, 1989
6. Pantel K, Izbicki JR, Angstwurm M, et al: Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 53:1027-1031, 1993
7. Schlimok G, Funke I, Holzmann B, et al: Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci USA 84:8672-8676, 1987
8. Funke I, Fries S, Jauch KW: Tumorzellnachweis im Knochenmark. Chirurg 62:805-809, 1991
9. Moss TJ, Reynolds CP, Sather HN, et al: Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 324:219-226, 1991
10. Lindemann F, Schlimok G, Dirschedl P, et al: Prognostic significance of micrometastatic rumour cells in bone marrow of colorectal cancer patients. Lancet 340:685-689, 1992
11. Diel IJ, Kaufmann M, Goerner R, et al: Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J Clin Oncol 10:1534-1539, 1992
12. Berger U, Bettelheim R, Mansi JL, et al: The relationship between micrometastasis in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90:1-6, 1988
13. Mansi JL, Berger U, Easton D, et al: Micrometastasis in bone marrow in patients with primary breast cancer: Evaluation as an early predictor of bone metastases. Br Med J 295:1093-1096, 1987
14. Coombes RC, Berger U, Mansi JL, et al: Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer. NCI Monogr 1:51-53, 1986
15. Schlimok G, Funke I, Bock B, et al: Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 8:831-837, 1990
16. Laurèn R. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma. Act Pathol Microbiol Scand 64:31-34, 1965
17. International Union Against Cancer (UICC): TNM Classification of Malignant Tumors, in Hermanek P, Sobin LH (eds): Revised Edition Berlin, Germany Springer Verlag, 1992
18. Cordell JL, Falini B, Erber WN, et al: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229, 1984
19. Moll R, Franke WW, Schiller DL, et al: The catalogue of human cytokeratins: Pattern of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24, 1982
20. Debus E, Moll R, Franke WW, et al: Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol 114:121-30, 1984
21. Hollander M, Wolfe DA: Nonparametric Statistical Methods. New York, NY, Wiley, 1973, pp 67-75, 114-119
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
24. Cox DR. Regression models and life tables. J R Stat Soc B 34:187-220, 1972
25. Breimann L, Friedmann JH, Olsken RA, et al: Classification and Regression Trees. Belmont, CA, Waelswoth, 1984
26. Ichiyoshi Y, Toda T, Minamisono Y, et al: Recurrence in early gastric cancer. Surgery 107:489-495, 1990
27. Juhl H, Stritzel M, Wroblewski A, et al: Immunoctological detection of micrometastatic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 57:330-335, 1994
28. Schlimok G, Funke I, Pantel K, et al: Micrometastatic tumour cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance. Eur J Cancer 27:1461-1465, 1991
29. Friess S: Mikrometastasierung bei Mammakarzinom mit eingehender Analyse des quantitativen epithelialen Zellnachweises. Inaugural Dissertation. LM-Universität München, München Germany, 1995
30. Osborne MP, Rosen PP: Detection and management of bone marrow micrometastases in breast cancer. Oncology 8:25-31, 1994
31. Knapp AC, Franke WW: Spontaneous losses of control of cytokeratin gene expression in transformed, non-epithelial human cells occurring at different levels of regulation. Cell 59:67-79, 1989
32. Pantel K, Koprowski H, Riethmüller G: Meeting Report: Conference on cancer micrometastasis: Biology, methodology and clinical significance. Int J Oncol 3:1019-1022, 1993
33. Cote RJ, Rosen ML, Old LJ, et al: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9:1749-1756, 1991
34. Gerhard M, Juhl H, Kalthoff H, et al: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reyction. J Clin Oncol 12:725-729, 1994
35. Wood DP, Banks ER, Humphreys S, et al: Identification of bone marrow micrometastes in patients with prostate cancer. Cancer 74:2533-2540, 1994
36. Schoenfeld A, Luqmani Y, Smith D, et al: Detection o breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54:2986-2990, 1994
37. Gross HJ, Verwer B, Houck D, et al: Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10-7. Proc Natl Acad Sci USA 92:537-541, 1995
38. Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1:571-573, 1989
39. Hart IR, Saini A: Biology of tumour metastasis. Lancet 339:1453-1461, 1992
40. Mansi JL, Berger U, McDonnell T, et al: The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 7:445-449, 1989
41. Pantel K, Schlimok G, Braun S, et al: Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85:1419-1424, 1993